12/19
07:04 pm
crsp
Is Trending Stock CRISPR Therapeutics AG (CRSP) a Buy Now? [Yahoo! Finance]
Low
Report
Is Trending Stock CRISPR Therapeutics AG (CRSP) a Buy Now? [Yahoo! Finance]
12/19
07:22 am
crsp
Is CRISPR Therapeutics a Buy, Sell, or Hold in 2026? [Yahoo! Finance]
Low
Report
Is CRISPR Therapeutics a Buy, Sell, or Hold in 2026? [Yahoo! Finance]
12/18
12:43 pm
crsp
2 Growth Stocks to Invest $1,000 in Right Now [Yahoo! Finance]
Low
Report
2 Growth Stocks to Invest $1,000 in Right Now [Yahoo! Finance]
12/17
07:42 pm
crsp
CRISPR Therapeutics AG (CRSP) Falls More Steeply Than Broader Market: What Investors Need to Know [Yahoo! Finance]
Low
Report
CRISPR Therapeutics AG (CRSP) Falls More Steeply Than Broader Market: What Investors Need to Know [Yahoo! Finance]
12/17
06:36 pm
crsp
2 Monster Stocks in the Making to Buy and Hold [Yahoo! Finance]
Low
Report
2 Monster Stocks in the Making to Buy and Hold [Yahoo! Finance]
12/12
01:24 pm
crsp
2 Healthcare Stocks to Buy Ahead of the New Year [Yahoo! Finance]
Low
Report
2 Healthcare Stocks to Buy Ahead of the New Year [Yahoo! Finance]
12/9
04:43 am
crsp
Does CRISPR Therapeutics Around 57 Dollars Reflect Its DCF Value After Recent Rally? [Yahoo! Finance]
Neutral
Report
Does CRISPR Therapeutics Around 57 Dollars Reflect Its DCF Value After Recent Rally? [Yahoo! Finance]
12/4
10:31 am
crsp
Cathie Wood's Buys And Rumors Aside, Here's Why Crispr Therapeutics Is A Strong Buy [Seeking Alpha]
Low
Report
Cathie Wood's Buys And Rumors Aside, Here's Why Crispr Therapeutics Is A Strong Buy [Seeking Alpha]
12/2
02:16 pm
crsp
CRISPR Therapeutics: CTX310 De-Risks, CASGEVY Disappoints Amid Takeover Rumors [Seeking Alpha]
Low
Report
CRISPR Therapeutics: CTX310 De-Risks, CASGEVY Disappoints Amid Takeover Rumors [Seeking Alpha]
12/1
05:37 am
crsp
What CRISPR Therapeutics' (CRSP) Latest Trial Results Mean for Investors [Yahoo! Finance]
Low
Report
What CRISPR Therapeutics' (CRSP) Latest Trial Results Mean for Investors [Yahoo! Finance]
11/29
04:21 pm
crsp
CRISPR Therapeutics (CRSP): Assessing Valuation in Light of Recent Share Price Volatility [Yahoo! Finance]
Medium
Report
CRISPR Therapeutics (CRSP): Assessing Valuation in Light of Recent Share Price Volatility [Yahoo! Finance]
11/29
01:13 pm
crsp
Citizens Maintains Market Outperform on CRISPR Therapeutics (CRSP) Despite Casgevy Slowdown [Yahoo! Finance]
Medium
Report
Citizens Maintains Market Outperform on CRISPR Therapeutics (CRSP) Despite Casgevy Slowdown [Yahoo! Finance]
11/26
07:02 am
crsp
CRISPR Therapeutics (NASDAQ:CRSP) was given a new $74.00 price target on by analysts at Chardan Capital.
Low
Report
CRISPR Therapeutics (NASDAQ:CRSP) was given a new $74.00 price target on by analysts at Chardan Capital.
11/25
08:51 am
crsp
Oppenheimer Reaffirms Outlook on CRISPR Therapeutics (CRSP) After Encouraging Q3 Earnings Performance [Yahoo! Finance]
Medium
Report
Oppenheimer Reaffirms Outlook on CRISPR Therapeutics (CRSP) After Encouraging Q3 Earnings Performance [Yahoo! Finance]
11/19
07:38 pm
crsp
This Leading Gene-Editing Stock Could Be Going Private. Should You Buy Its Shares First? [Yahoo! Finance]
Medium
Report
This Leading Gene-Editing Stock Could Be Going Private. Should You Buy Its Shares First? [Yahoo! Finance]
11/19
01:42 pm
crsp
RBC Capital Lifts CRISPR Therapeutics (CRSP) Target to $50, Keeps Sector Perform [Yahoo! Finance]
Low
Report
RBC Capital Lifts CRISPR Therapeutics (CRSP) Target to $50, Keeps Sector Perform [Yahoo! Finance]
11/19
11:28 am
crsp
The Biotech Sector is Seeing a Major Boost From Programmable Cell Therapies in Chronic Disease Care [Canadian Business Journal (Canada)]
Low
Report
The Biotech Sector is Seeing a Major Boost From Programmable Cell Therapies in Chronic Disease Care [Canadian Business Journal (Canada)]
11/17
12:23 am
crsp
Positive CTX310 Phase 1 Results Might Change The Case For Investing In CRISPR Therapeutics (CRSP) [Yahoo! Finance]
Medium
Report
Positive CTX310 Phase 1 Results Might Change The Case For Investing In CRISPR Therapeutics (CRSP) [Yahoo! Finance]
11/14
07:08 pm
crsp
CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know [Yahoo! Finance]
Medium
Report
CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know [Yahoo! Finance]
11/11
08:28 am
crsp
Evox Therapeutics Appoints Douglas Treco, Ph.D., to Board of Directors [Yahoo! Finance]
Low
Report
Evox Therapeutics Appoints Douglas Treco, Ph.D., to Board of Directors [Yahoo! Finance]
11/11
08:16 am
crsp
CRISPR Therapeutics (NASDAQ:CRSP) had its price target lowered by analysts at Robert W. Baird from $52.00 to $44.00. They now have a "neutral" rating on the stock.
Low
Report
CRISPR Therapeutics (NASDAQ:CRSP) had its price target lowered by analysts at Robert W. Baird from $52.00 to $44.00. They now have a "neutral" rating on the stock.
11/11
07:03 am
crsp
CRISPR Therapeutics (NASDAQ:CRSP) had its "sector perform" rating reaffirmed by analysts at Royal Bank Of Canada.
Low
Report
CRISPR Therapeutics (NASDAQ:CRSP) had its "sector perform" rating reaffirmed by analysts at Royal Bank Of Canada.
11/11
06:02 am
crsp
CRISPR Therapeutics (NASDAQ:CRSP) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
CRISPR Therapeutics (NASDAQ:CRSP) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
11/10
12:06 pm
crsp
CRISPR Therapeutics (NASDAQ:CRSP) had its price target lowered by analysts at Needham & Company LLC from $81.00 to $80.00. They now have a "buy" rating on the stock.
Low
Report
CRISPR Therapeutics (NASDAQ:CRSP) had its price target lowered by analysts at Needham & Company LLC from $81.00 to $80.00. They now have a "buy" rating on the stock.
11/10
08:18 am
crsp
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results [Yahoo! Finance]
Medium
Report
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results [Yahoo! Finance]